# Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

> **NCT03617341** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 200 (estimated)

## Conditions studied

- Metastatic Breast Cancer With HER2 Positive
- Triple Negative Breast Cancer

## Interventions

- **PROCEDURE:** Brain MRI

## Key facts

- **NCT ID:** NCT03617341
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-02
- **Primary completion:** 2021-07-30
- **Final completion:** 2023-06-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03617341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03617341, "Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03617341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*